Videos

Paul Rainville, PharmD, CSP, AAHIVP, a clinical pharmacist and subject matter expert with Shields Health Solutions, discussed the current state of HIV in the United States

Robert Sidonio Jr, MD, MSc, shares insights on monitoring and managing side effects in hemophilia A treatment to ensure patient safety and adherence.

Experts discuss best practices for improving patient adherence to hemophilia A therapies, including addressing adherence issues and patient engagement.

Nick Gazda, PharmD, MS, BCPS, CSP assistant director of Specialty Pharmacy Services, discusses how the pharmacy landscape is constantly changing, leading pharmacists to remain nimble and open.

Calvin Tucker, PharmD, MBA, FCCM, FFSHP, Pharmacy Manager for the Cancer Care Pharmacy discusses the unique and valuable role pharmacist have within the health care community

Crystal Toribio, PharmD, Transitions of Care Clinical Pharmacist at St. Francis Hospital discusses the impact of direct patient care within her role to highlight this American Pharmacists Month.

Kate Smullen, PharmD, CSP, MSCS, senior director of clinical services at Shields Health Solutions, discussed her journey to becoming a pharmacist and how she has been celebrating this American Pharmacists Month.

Amber Bush, PharmD, RPh, BCPS, BCCCP, pharmacy research coordinator for Mayo Clinic discusses the future of pharmacy through her role within research clinical trials

Ramesh Cheruvu, PharmD, pharmacist and pharmacy manager at Health Mart Family Pharmacy at McKesson, discussed his journey in the pharmaceutical industry and how it has changed since he became a pharmacist.

Dr Kettle outlines NCCN guideline-directed therapy surrounding CDK4/6 inhibitors.

Adverse event profiles of several approved CDK4/6 inhibitors are discussed.

Christina Barrington, PharmD, vice president of pharmacy programs at Priority Health, discusses current disruptors in the marketplace and high-cost drugs.

The vice president of pharmacy operations at American Oncology Network discusses the 340B Drug Pricing Program and its growth and impact on community oncology.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses SDOH and how pharmacists, particularly within community pharmacies, are the most accessible health care providers and can play a crucial role in advocating for patients.

Craig Sastic, PharmD, MBA, BCPS, discussed how he has seen the pharmacy field change throughout his career.

Viktor Grunwald, MD, PhD, discusses the post-hoc analysis of the phase 3 CLEAR trial investigating the combination treatment in the first-line setting for advanced renal cell carcinoma.

Atta Chowdhry, RPh, discusses treatment approaches for acute episodes and prophylaxis in patients with hemophilia A.

Robert Sidonio Jr, MD, MSc, discusses patient-centered therapy choices, highlighting the diverse options and considerations for hemophilia A treatment.

Rimple Gabri, PharmD, a pharmacist with Giant Pharmacy for nearly 3 decades, shares her journey into the pharmacy profession.

Taking pharmacists out of the dispensing setting and placing them in communities as educators on drug safety is reaping rewards.

Vanessa Campbell, PharmD, the director of Clinical Pharmacy at UPMC Health Plan, discusses her role and responsibilities, which include managing a team of pharmacists involved in patient outreach and clinical disease state management.

Saira A. Jan, MS, PharmD, discussed a novel pilot program in New Jersey aiming to expand home infusion services in oncology.

Thrifty White has created a newsletter sharing the impacts their pharmacists have on patients, including one pharmacist who recognized stroke symptoms and was able to get the patient help.

Mike Schuh, PharmD, MBA, FAPhA, FFSHP, a medication management pharmacist at the Mayo Clinic in Florida, discusses his journey into the pharmacy profession and the evolution of pharmacists from product-oriented to clinical professionals.

Erica Marchese, PharmD, MHA, BCPS, BCOP, BCSCP, discussed the revision of pharmacy and the contributing roles within the pharmacy team.

In her final discussion, Dr Moore analyzes key differences between the NATALEE and moncarchE trials.

Jacob Kettle, PharmD, BCOP, joins Drs Haumschild and DiMarco in a conversation surrounding findings from the SONIA trial and their impact on shifting mBC treatment strategies.

Expert panelists discuss the impact of CDK4/6 inhibitor therapy on progression-free and overall survival.

Timothy O’Shea, MS, PharmD, discussed the growth of home infusion programs and how they benefit patients.

In addition to celebrating his colleagues, Medrano said he is taking more time for mindfulness and meditation before going to work each day.